Drug therapy : GanciclovirCRUMPACKER, C. S.The New England journal of medicine. 1996, Vol 335, Num 10, pp 721-729, issn 0028-4793Article

Molecular targets of antiviral therapyCRUMPACKER, C. S. II.The New England journal of medicine. 1989, Vol 321, Num 3, pp 163-172, issn 0028-4793Article

Mechanism of action of foscarnet against viral polymerasesCRUMPACKER, C. S.The American journal of medicine. 1992, Vol 92, Num 2A, pp 2A.3S-2A.7S, issn 0002-9343Conference Paper

Expression of herpes simplex virus type 1 DNA polymerase gene by in vitro translation and effects of gene deletions on activityDORSKY, D. I; CRUMPACKER, C. S.Journal of virology. 1988, Vol 62, Num 9, pp 3224-3232, issn 0022-538XArticle

Ribavirin treatment of murine coxsackievirus B₃ myocarditis with analyses of lymphocyte subsetsKISHIMOTO, C; CRUMPACKER, C. S; ABELMANN, W. H et al.Journal of the American College of Cardiology. 1988, Vol 12, Num 5, pp 1334-1341, issn 0735-1097Article

Drugs five years late: acyclovirDORSKY, D. I; CRUMPACKER, C. S.Annals of internal medicine. 1987, Vol 107, Num 6, pp 859-874, issn 0003-4819Article

Prevention of viral myocarditis with recombinant human leukocyte interferon α A/D in a murine modelMATSUMORI, A; CRUMPACKER, C. S; ABELMANN, W. H et al.Journal of the American College of Cardiology. 1987, Vol 9, Num 6, pp 1320-1325, issn 0735-1097Article

Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex virusesCHATIS, P. A; CRUMPACKER, C. S.Virology (New York, NY). 1991, Vol 180, Num 2, pp 793-797, issn 0042-6822, 5 p.Article

Prevention of murine coxsackie B3 viral myocarditis and associated lymphoid organ atrophy with recombinant human leucocyte interferon α A/DKISHIMOTO, C; CRUMPACKER, C. S; ABELMANN, W. H et al.Cardiovascular research. 1988, Vol 22, Num 10, pp 732-738, issn 0008-6363Article

Resistance of herpersviruses to antiviral drugsCHATIS, P. A; CRUMPACKER, C. S.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 8, pp 1589-1595, issn 0066-4804Article

Site-specific mutagenesis of a highly conserved region of the herpes simplex virus type 1 DNA polymerase geneDORSKY, D. I; CRUMPACKER, C. S.Journal of virology. 1990, Vol 64, Num 3, pp 1394-1397, issn 0022-538XArticle

Overview of cytomegalovirus infections in HIV-infected patients : current therapies and future strategiesCRUMPACKER, C. S; HEATH-CHIOZZI, M.Journal of acquired immune deficiency syndromes. 1991, Vol 4, pp S1-S5, issn 0894-9255, SUP1Conference Paper

Incorporation of 1-β-D-arabinofuranosylcytosine into DNA and mutagenesis of herpes simplex virus type 1BUBLEY, G. J; CRUMPACKER, C. S; SCHNIPPER, L. E et al.Antimicrobial agents and chemotherapy. 1986, Vol 29, Num 4, pp 716-719, issn 0066-4804Article

Serial immunologic identification of lymphocyte subsets in murine coxsackievirus B3 myocarditis: different kinetics and significance of lymphocyte subsets in the heart and in peripheral bloodKISHIMOTO, C; MISAKI, T; CRUMPACKER, C. S et al.Circulation (New York, N.Y.). 1988, Vol 77, Num 3, pp 645-653, issn 0009-7322Article

Treatment of viral of viral myocarditis with ribavirin in an animal preparationMATSUMORI, A; WANG, H; ABELMANN, W. H et al.Circulation (New York, N.Y.). 1985, Vol 71, Num 4, pp 834-839, issn 0009-7322Article

In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virusSTEINBERG, H. N; CRUMPACKER, C. S; CHATIS, P. A et al.Journal of virology. 1991, Vol 65, Num 4, pp 1765-1769, issn 0022-538X, 5 p.Article

Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virusMATSUMORI, A; KAWAI, C; CRUMPACKER, C. S et al.Japanese Circulation Journal. 1987, Vol 51, Num 6, pp 661-664, issn 0047-1828Article

Repair of DNA following incorporation of 1-β-D-arabinofuranosylcytosine into herpes simplex virus type I = Réparation du DNA à la suite de l'incorporation de 1-bêta-D-arabinofuranosylcytosine dans le virus herpès simplex de type IBUBLEY, G. J; CRUMPACKER, C. S; SCHNIPPER, L. E et al.Cancer research (Baltimore). 1984, Vol 44, Num 5, pp 1813-1818, issn 0008-5472Article

Varicella-zoster virus disease in patients with human immunodeficiency virus infectionGULICK, R. M; HEATH-CHIOZZI, M; CRUMPACKER, C. S et al.Archives of dermatology (1960). 1990, Vol 126, Num 8, pp 1086-1088, issn 0003-987X, 3 p.Article

Virus vaccine and passive immunization for the prevention of viral myocarditis in miceMATSUMORI, A; CRUMPACKER, C. S; ABELMANN, W. H et al.Japanese Circulation Journal. 1987, Vol 51, Num 12, pp 1362-1364, issn 0047-1828Article

A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection : A phase I studyDEZUBE, B. J; DAHL, T. A; WONG, T. K et al.The Journal of infectious diseases. 2000, Vol 182, Num 2, pp 607-610, issn 0022-1899Article

Antiviral resistance in clinical practiceKIMBERLIN, D. W; CRUMPACKER, C. S; STRAUS, S. E et al.Antiviral research. 1995, Vol 26, Num 4, pp 423-438, issn 0166-3542Conference Paper

Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDSDEZUBE, B. J; PARDEE, A. B; CRUMPACKER, C. S et al.Journal of acquired immune deficiency syndromes. 1993, Vol 6, Num 7, pp 787-794, issn 0894-9255Article

Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replicationLI, C. J; ZHANG, L. J; DEZUBE, B. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 5, pp 1839-1842, issn 0027-8424Article

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infectionKAHN, J. O; LAGAKOS, S. W; SACKS, H. S et al.The New England journal of medicine. 1992, Vol 327, Num 9, pp 581-587, issn 0028-4793Article